A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies

NCT07719348 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia
Chronic Myelomonocytic Leukemia
Myelodysplastic Syndrome Acute Myeloid Leukemia

Interventions

DRUG: S241656
DRUG: Posaconazole

Sponsor

Servier